http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112813158-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
| filingDate | 2021-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112813158-B |
| titleOfInvention | miRNA markers and their application in the auxiliary diagnosis of myocardial fibrosis |
| abstract | The present invention discloses miRNA markers related to the auxiliary diagnosis of myocardial fibrosis and its application. Through high-throughput sequencing analysis technology, hsa-miR-6802-3p and hsa differentially expressed in patients with myocardial fibrosis are screened out. ‑miR‑1229‑3p, further cell experiments verified that the miRNA biomarkers hsa‑miR‑6802‑3p and hsa‑miR‑1229‑3p can be used in the clinical auxiliary diagnosis of myocardial fibrosis, for early diagnosis of myocardial fibrosis At the same time, it also provides a drug target for the clinical preparation of drugs against myocardial fibrosis, which is helpful to realize the targeted therapy of myocardial fibrosis. |
| priorityDate | 2021-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.